Dr. Marwa Abozed | Antibiotic | Best Researcher Award

Dr. Marwa Abozed | Antibiotic | Best Researcher Award

Lecturer at Zagazig University Faculty of Human Medicine, Egypt

Marwa Fady Mohamed Abd El Hamed is an esteemed academic and microbiologist whose work extensively focuses on the development and enhancement of antibiotic treatments. With a rich background in pharmaceutical and medical microbiology, she has devoted much of her career to antibiotic-related research including resistance mechanisms and antibiofilm strategies. Her journey through academia and healthcare institutions is consistently guided by her passion for antibiotics, leading to significant contributions in infection control and innovative antimicrobial applications. She consistently demonstrates leadership in advancing knowledge related to antibiotic therapies, both as a scholar and educator. Her roles across institutions in Egypt, Saudi Arabia, and the USA have enriched her expertise and strengthened her resolve to combat the global antibiotic crisis. Her published work clearly reflects her dedication to antibiotic-related innovations, with substantial impact on antifungal, antibacterial, and antibiofilm therapeutic developments. With every academic, clinical, and research role she undertakes, antibiotics remain central to her mission. Her lectures, student guidance, and scientific investigations are deeply intertwined with antibiotic studies, creating a significant footprint in pharmaceutical microbiology. She is widely recognized for her continuous focus on antibiotic innovation, antibiotic resistance, and antibiotic-based natural compounds. Through publications and international conferences, she continues to highlight the critical importance of antibiotics in modern medicine.

Professional Profile 

ORCID

Education

Marwa Fady’s academic background is a testament to her enduring commitment to the field of antibiotics. She earned her Bachelor’s degree in Pharmacy, followed by a Master’s and PhD in Microbiology from Zagazig University. Her graduate and postgraduate work revolved around antibiotic resistance and microbiological investigations of pathogenic strains. Her education incorporated extensive research in antibiotic mechanism, antibiotic synergy, and biofilm inhibition. She later became a visiting scholar at the University of Dayton, USA, where she expanded her focus on global antibiotic challenges. Her degrees serve as a foundation for her life-long pursuit of antibiotic innovations, consistently integrating antibiotics in both theoretical and practical settings. Through every academic milestone, she has maintained a strong emphasis on antibiotic efficacy, antibiotic mechanisms, and antibiotic applications. Her learning journey solidified her expertise in antibiotics, allowing her to contribute to developing next-generation antibiotic solutions. Her thesis and research projects consistently investigated antibiotic-related phenomena, underlining her unwavering academic alignment with antibiotic science. These educational stages nurtured her growth in antibiotic strategies, antibiotic research techniques, and antibiotic policy studies. Her educational path has been deeply intertwined with antibiotics, establishing her as a knowledgeable and credible figure in the antibiotic-focused scientific community.

Experience

Marwa Fady’s professional career has been shaped by her focus on antibiotics in multiple academic and clinical roles. From teaching microbiology and pharmaceutical sciences to managing infection control programs, antibiotics have remained central to her responsibilities. As Assistant Professor at Modern University for Technology and Information, she designs coursework heavily centered on antibiotics, including their classification, resistance mechanisms, and clinical applications. Her tenure at Buraidah Private Colleges and Al-Ghad International Colleges further enriched her hands-on experience in antibiotic research and laboratory practices. During her time in the quality assurance departments, she led efforts in evaluating antibiotic stewardship programs. Her responsibilities included guiding graduation projects with antibiotic research themes, ensuring that antibiotic education remained a priority. As a faculty member at Delta University, she supervised student training in antibiotic susceptibility testing and antibiotic prescription monitoring. She also contributed to infection control initiatives at Zagazig University Hospital, focusing on antibiotic use and evaluation. Across all her professional stations, the common thread is the integration and promotion of antibiotics in teaching, practice, and research. Her career is a dynamic embodiment of antibiotic commitment, and each position she held has contributed to building her legacy in antibiotics-driven academia and clinical microbiology.

Research Interest

Marwa Fady’s primary research interests revolve around antibiotics, particularly in the context of resistance, biofilms, and novel delivery systems. She explores how antibiotics interact with microbial cells and investigates ways to enhance antibiotic efficacy through nanotechnology and natural compounds. Her projects delve into antibiotic resistance in clinical isolates, the identification of antibiofilm agents, and the synthesis of antibiotic-loaded nanocarriers. A significant focus of her research is the modification of antibiotic functionality to overcome microbial resistance and reduce toxicity. She is also interested in discovering natural sources of antibiotics, evaluating plant extracts, and developing formulations that potentiate traditional antibiotics. In addition, her research addresses antibiotic-associated complications in infection control, advocating for rational antibiotic use and promoting antibiotic stewardship. By studying bacteria’s genetic and phenotypic responses to antibiotics, she contributes to understanding resistance development. Her experiments consistently integrate antibiotic testing methods, pharmacokinetics, and synergistic approaches for treatment improvement. Her scientific publications clearly illustrate her unwavering focus on antibiotics, as she bridges microbiology with nanomedicine. Her research not only deepens our knowledge of antibiotics but also supports the creation of advanced antibiotic therapies capable of addressing current global challenges in microbial resistance and public health threats.

Awards and Honors

Marwa Fady has received numerous recognitions for her contributions to antibiotic research and microbiology. Her invitation as a session speaker and poster presenter at various international scientific conferences underlines her expertise in antibiotics. Notably, she represented her antibiotic-related work at the 7th International Conference on Drug Discovery & Therapy in the UAE. Her position as a reviewer for Bentham journals and editorial board member of Frontiers in Environmental Microbiology further acknowledges her credibility in antibiotic-focused publications. She has been repeatedly recognized for her scientific outputs on antibiotics, including antifungal, antibacterial, and antibiofilm activities. These honors reflect her prominence in the field of antibiotic innovation. Her teaching awards and institutional acknowledgments also credit her excellence in antibiotic education and mentorship. Whether through editorial responsibilities or scientific presentations, she has championed the cause of antibiotic advancement. Each award symbolizes a milestone in her antibiotic-centered journey. Her achievements continue to inspire academic and clinical communities in developing new solutions to antibiotic resistance. Marwa Fady's work continues to attract institutional, national, and international recognition, always grounded in the development, improvement, and global application of antibiotics as life-saving therapeutic agents.

Research Skills

Marwa Fady has developed advanced research skills with a clear emphasis on antibiotics, covering experimental design, microbiological techniques, and molecular diagnostics. Her expertise includes culturing resistant strains, evaluating antibiotic susceptibility, and studying biofilm disruption using antibiotics. She is skilled in operating instruments critical for antibiotic analysis, such as microplate readers, incubators, and spectrophotometers. Marwa also masters modern molecular biology tools like PCR, electrophoresis, and genetic sequencing, often applying them to analyze antibiotic resistance genes. Her ability to design and execute in vitro and in vivo studies enables comprehensive evaluations of antibiotic efficacy. She excels in nanomedicine approaches for antibiotic delivery, antibiotic-loaded hydrogel development, and pharmacological assessments. Data interpretation and biostatistical analysis are also part of her skillset, especially in the context of antibiotic resistance trends. She regularly integrates computational tools and in silico modeling to predict antibiotic behaviors. Her research skills reflect her ability to navigate interdisciplinary frameworks involving microbiology, pharmacology, and biotechnology. These competencies have driven the success of numerous antibiotic research projects. Her methodological rigor and innovative outlook make her a key figure in antibiotic discovery and application. Her skills consistently serve the scientific community in addressing antibiotic resistance and refining therapeutic use of antibiotics.

Publications

Title: Chitosan-Based Intelligent Microneedles for Delivery of Amphotericin B Loaded Oleosomes: Antifungal Ocular Patch Targeting for Effective Against Fungal Keratitis Using Rabbit Model via TLR4/NLRP3 Pathway
Author: Marwa Fady
Journal: International Journal of Nanomedicine
Publication Date: 2025-04-30

Title: Polylactic-Co-Glycolic Acid/Alginate/Neem Oil-Reduced Graphene Oxide as a pH-Sensitive Nanocarrier for Hesperidin Drug Delivery: Antimicrobial and Acute Otitis Media Assessments
Authors: Saeed Al Zuhairy, Sammar Fathy Elhabal, Mohamed Fathi Mohamed Elrefai, Sandra Hababeh, Jakline Nelson, Marwa Fady, Nahla A. Elzohairy, Tassneim M. Ewedah, Ibrahim S. Mousa, Ahmed M. Hamdan
Journal: Pharmaceuticals
Publication Date: 2025-03-07

Title: Effect of β-sitosterol on PEL and PSL of Pseudomonas aeruginosa
Authors: Marwa Fady, Y. Irie, R.M. Aljowaie, S. Musaed Almutairi
Journal: Journal of King Saud University - Science
Publication Year: 2024

Title: Enhancing Photothermal Therapy for Antibiofilm Wound Healing: Insights from Graphene Oxide-Cranberry Nanosheet Loaded Hydrogel in vitro, in silico, and in vivo Evaluation
Authors: Sammar Elhabal, Saeed Al Zuhairy, Mohamed El-Nabarawi, Mohamed Elrefai, Mai Shoela, Sandra Hababeh, Jakline Nelson, Mohamed Abdel Khalek, Marwa Fady, Nahla Elzohairy, et al.
Journal: International Journal of Nanomedicine
Publication Date: 2024-12

Title: Evaluation of antibiofilm and cytotoxicity effect of Rumex vesicarius methanol extract
Authors: Marwa Fady, H. Rizwana, K.M. Alarjani, M.A. Alghamdi, S.S. Ibrahim, J. Geyer, A. Abbas
Journal: Open Chemistry
Publication Year: 2023

Title: Efficacy of Ethanol Extract from Leaves Of Malva parviflora to Inhibit Bacterial Biofilm Formation
Authors: Marwa Abozed, Nadia Hashish, Magda Gazer
Journal: Journal of Molecular Biology Research
Publication Date: 2018-04-19

Conclusion

Marwa Fady Mohamed Abd El Hamed is a distinguished researcher whose career is firmly anchored in the study and advancement of antibiotics. Her academic journey, professional practice, and research excellence are harmoniously united by a common goal: improving antibiotic science. Her work not only explores the limits of antibiotic resistance but also proposes novel solutions through nanotechnology and natural compounds. From guiding students in antibiotic-focused courses to publishing breakthrough findings in peer-reviewed journals, her commitment remains unwavering. Marwa’s global exposure and multidisciplinary engagements strengthen her voice in the antibiotic community. Her role as a mentor, speaker, and scholar reinforces the relevance of antibiotics in education, research, and healthcare policy. With each project and publication, she contributes to resolving the global antibiotic crisis, one study at a time. Her vision includes not just understanding antibiotics but also applying them strategically to benefit public health. Her achievements are a testament to how antibiotics can be central to both personal expertise and global innovation. In every capacity—educator, researcher, clinician—antibiotics have guided her mission and continue to define her legacy in microbiology and pharmaceutical science.

Xiaoxiao Zhong – Mechanism of Resistance – Best Researcher Award

Xiaoxiao Zhong - Mechanism of Resistance - Best Researcher Award

the THIRD Xiangya hospital, csu - China

AUTHOR PROFILE

ORCID

🧬 ACADEMIC FOUNDATION AND EARLY INQUIRY

Dr. Xiaoxiao Zhong began her journey in molecular biology with a keen curiosity about the Mechanism of Resistance within metabolic and glandular disorders, particularly in cancer biology. Her academic training laid the foundation for decoding the intricate cellular and molecular landscapes of diseases, especially breast cancer. The Mechanism of Resistance became a recurring theme as she explored glycosylation processes and immune microenvironments during her early research. Her initial studies bridged theory and application, combining computational and experimental approaches to understand how cancers evade immune detection. These formative years equipped her with a robust understanding of translational oncology and introduced her to the emerging significance of the tumor microenvironment. Zhong's early academic success fueled her drive to pursue multidisciplinary integration—especially in bioinformatics, transcriptomics, and high-throughput data analysis. Her pursuit to reveal the Mechanism of Resistance in disease pathways began with small but significant steps, contributing to larger discoveries that would later shape her career. Her work at Central South University provided not only a supportive academic environment but also exposure to state-of-the-art research tools and collaborative frameworks. These experiences instilled in her a lifelong mission to uncover the biological processes that define cancer behavior and their connection to the Mechanism of Resistance.

🧪 PROFESSIONAL ADVANCEMENT IN TRANSLATIONAL RESEARCH

As a Medicine Doctor at The Third Xiangya Hospital of Central South University, Dr. Xiaoxiao Zhong steadily advanced her professional career by centering her investigations around the Mechanism of Resistance in cancer therapy. Her professional endeavors are marked by an integrative approach to both clinical and laboratory settings, where she collaborates across disciplines to identify new prognostic markers and therapeutic targets. Zhong's work delves into how dysregulated metabolic pathways contribute to the Mechanism of Resistance in breast cancer. Her projects—sixteen in number—underscore her commitment to applied research with translational outcomes. She navigates between in vitro experimentation and multi-omics bioinformatics with precision, making her work both pioneering and clinically relevant. The Mechanism of Resistance is not only a research theme but a clinical puzzle she strives to solve, influencing treatment personalization and long-term patient outcomes. As a reviewer for scientific journals and a member of national research associations, she maintains active roles in advancing oncology research. Her contribution to the General Program of the National Natural Science Foundation of China reflects her recognition as a key scientific mind. Through it all, the Mechanism of Resistance remains central to her objectives, shaping the way future therapies may overcome cancer’s most persistent barriers.

🔬 RESEARCH INNOVATION AND DISCOVERY FOCUS

Dr. Xiaoxiao Zhong’s innovative research revolves around decoding the tumor microenvironment (TME) and understanding the Mechanism of Resistance that allows cancer cells to evade immune surveillance and therapeutic interventions. Her groundbreaking development of the 22-gene TME-risk signature (TMERS) has proven instrumental in advancing prognostic predictions in breast cancer. She consistently focuses on the Mechanism of Resistance embedded in glycosylation processes and immune evasion tactics, providing a dual-layered analysis that merges structural biology with immune profiling. Zhong’s research innovations also explore the role of key glycosyltransferase genes like KLRB1, whose regulatory influence she established through rigorous functional assays. Her integration of WGCNA, LASSO Cox regression, and DEG analysis demonstrates her mastery of both computational tools and biological insight. By repeatedly returning to the Mechanism of Resistance across different datasets and models, Zhong reinforces the centrality of this concept in cancer biology. Her studies do not merely describe pathways—they clarify function and mechanism. Moreover, these findings create pathways to new therapeutic interventions, especially in tumors that exhibit high resistance profiles. Zhong’s innovative strategy of combining multi-omics and experimental models ensures that her contributions remain at the frontier of cancer research, with the Mechanism of Resistance as her guiding lens.

🧠 IMPACT ON ONCOLOGY AND BIOMARKER DEVELOPMENT

The clinical and research community has benefitted immensely from Dr. Xiaoxiao Zhong’s deep analysis of the Mechanism of Resistance, especially in breast cancer. Her identification of novel prognostic biomarkers such as KLRB1 helps stratify patients more accurately, allowing clinicians to anticipate resistance-related outcomes before therapy begins. The Mechanism of Resistance in TME modeling has been at the heart of her biomarker discovery process, supporting patient-specific therapy protocols. Through gene-expression profiling, Zhong has uncovered patterns within resistant tumor populations, revealing how microenvironmental elements such as stromal and immune cells interact to foster resistance. These insights enable the classification of molecular subtypes and open avenues for personalized medicine. Her impact also extends to public repositories like the GEO database, where her models have been independently validated. Importantly, her work shines in translational relevance—where research moves from bench to bedside. She continuously examines the Mechanism of Resistance from various biological angles, ensuring a comprehensive understanding of cancer progression. This dedication not only enhances biomarker precision but reshapes diagnostic frameworks across oncology. With each study, Zhong solidifies her reputation as a forward-thinking researcher who blends innovation with applicability, driven by the persistent question: how do we decode and defeat the Mechanism of Resistance in cancer?

🏅 ACCOLADES, AFFILIATIONS, AND PROFESSIONAL RECOGNITION

Dr. Xiaoxiao Zhong’s academic and professional excellence has earned her increasing recognition both nationally and internationally. Her focus on the Mechanism of Resistance has gained the attention of peers and scientific bodies, resulting in collaborations with prestigious institutions like the National Natural Science Foundation of China. Though early in her career, she has already published seven high-impact SCI and Scopus-indexed journal articles that frequently reference the Mechanism of Resistance as a central analytical theme. Zhong’s expertise also led to an appointment as a reviewer for Case Reports in Obstetrics and Gynecology, confirming her command in evaluating complex biomedical literature. She is an active member of the Chinese Association of Pathophysiology, where she contributes insights on the Mechanism of Resistance in metabolic dysfunctions and immune escape. Her reputation is further validated by multiple citations and collaborations across various interdisciplinary projects, demonstrating the applicability of her work. While she has not yet published books or patents, the rigor and innovation in her findings promise future expansion into these domains. Through her growing network and academic contributions, Zhong continues to shape the research landscape—always with the Mechanism of Resistance as the analytical compass guiding her toward discovery and recognition.

🌍 GLOBAL RELEVANCE AND SCIENTIFIC INFLUENCE

Dr. Zhong’s research impact goes beyond national borders, as her emphasis on the Mechanism of Resistance contributes to the global scientific understanding of cancer biology. By leveraging high-throughput technologies and integrative analytics, she provides blueprints for other researchers seeking to decipher resistance pathways. Her 22-gene TMERS model has become a reference point for scientists studying tumor heterogeneity and immunological factors across populations. The international community increasingly cites her work, appreciating the way it refines the conceptualization of the Mechanism of Resistance across diverse genetic and environmental contexts. Zhong’s influence lies in her ability to connect the molecular dots between immune signaling, metabolic flux, and therapeutic failure. These connections not only elevate her research’s relevance but also inspire adaptations of her model into other cancer types. Her collaborations with global datasets and open-access platforms enhance reproducibility and transparency in science. Moreover, by showcasing how the Mechanism of Resistance is both a molecular and clinical phenomenon, she encourages a more holistic treatment strategy that transcends national health systems. Dr. Zhong’s scientific influence lies not only in her publications but also in her capacity to shape a universal language around resistance—making her a cornerstone of the new age of precision oncology.

🌱 FUTURE DIRECTIONS AND LEGACY IN BIOMEDICINE

Looking ahead, Dr. Xiaoxiao Zhong aims to deepen her exploration of the Mechanism of Resistance through next-generation sequencing, single-cell analysis, and AI-driven modeling. Her vision includes creating adaptive therapeutic strategies that consider dynamic changes within the tumor microenvironment. She aspires to develop resistance-interrupting drugs informed by biomarker-based predictions and functional genomics. Her legacy will likely be defined by her persistence in unraveling the Mechanism of Resistance and translating it into viable treatment solutions. With growing citation indices and expanding collaborations, Zhong’s influence is poised to transform clinical practices and research methodologies alike. Her efforts are gradually building a blueprint for integrating systems biology into oncology clinics. While continuing to train and mentor young researchers, she aims to establish a resistance research consortium to pool global resources in this domain. By doing so, she ensures that future scientists inherit a solid foundation of knowledge and practical frameworks for targeting the Mechanism of Resistance in multiple disease contexts. In summary, her career is not just a collection of publications—it’s an evolving legacy grounded in inquiry, collaboration, and the relentless pursuit of overcoming the Mechanism of Resistance at every biological and clinical junction.

NOTABLE PUBLICATION

  • Title: Glycosylated protein-related microenvironmental features in breast cancer are associated with patient prognosis
    Author: Xiaoxiao Zhong et al.
    Journal: Mammalian Genome
    Date: 2025-05-24

 

  • Title: PCMT1 confirmed as a pan-cancer immune biomarker and a contributor to breast cancer metastasis
    Author: Xiaoxiao Zhong (with contributor Yiqi Liu)
    Journal: American Journal of Cancer Research
    Date: 2024

 

  • Title: Interpretable machine learning model based on the systemic inflammation response index and ultrasound features can predict central lymph node metastasis in cN0T1–T2 papillary thyroid carcinoma
    Author: Xiaoxiao Zhong et al.
    Journal: Gland Surgery
    Date: 2023-11

 

  • Title: Targeting survivin with Tanshinone IIA inhibits tumor growth and overcomes chemoresistance in colorectal cancer
    Author: Xiaoxiao Zhong et al.
    Journal: Cell Death Discovery
    Date: 2023-09-25

 

  • Title: Breast cancer combined with contralateral neck lymph node metastasis: a case report
    Author: Xiaoxiao Zhong et al.
    Journal: Diagnostic Pathology
    Date: 2022-12